Ottawa, Ontario--(Newsfile Corp. - June 4, 2021) - Innovative Medicines Canada (IMC) calls on the Federal Government to suspend the implementation of the Patented Medicines Prices Review Board's (PMPRB) regulatory changes which are set to come into effect on July 01, 2021.

The PMPRB regulatory changes will have significant unintended consequences...